172 related articles for article (PubMed ID: 31796534)
1. PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.
Song S; Wang Z; Li Y; Ma L; Jin J; Scott AW; Xu Y; Estrella JS; Song Y; Liu B; Johnson RL; Ajani JA
Mol Cancer Res; 2020 Mar; 18(3):390-402. PubMed ID: 31796534
[TBL] [Abstract][Full Text] [Related]
2. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.
Song S; Ajani JA; Honjo S; Maru DM; Chen Q; Scott AW; Heallen TR; Xiao L; Hofstetter WL; Weston B; Lee JH; Wadhwa R; Sudo K; Stroehlein JR; Martin JF; Hung MC; Johnson RL
Cancer Res; 2014 Aug; 74(15):4170-82. PubMed ID: 24906622
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
5. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression.
Wu Y; Shen L; Liang X; Li S; Ma L; Zheng L; Li T; Yu H; Chan H; Chen C; Yu J; Jia J
Cancer Med; 2019 Jul; 8(8):3965-3980. PubMed ID: 31145543
[TBL] [Abstract][Full Text] [Related]
9. Loss of
Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
Development; 2018 Mar; 145(6):. PubMed ID: 29511023
[TBL] [Abstract][Full Text] [Related]
10. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
11. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
12. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
13. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
14. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.
Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y
J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281
[TBL] [Abstract][Full Text] [Related]
16. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma.
Liu J; Zhao X; Wang K; Zhang X; Yu Y; Lv Y; Zhang S; Zhang L; Guo Y; Li Y; Yang A; Zhang R; Li J
Cell Death Dis; 2019 Jun; 10(6):452. PubMed ID: 31175271
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.
Thilakasiri P; O'Keefe RN; To SQ; Chisanga D; Eissmann MF; Carli AL; Duscio B; Baloyan D; Dmello RS; Williams D; Mariadason J; Poh AR; Pal B; Kile BT; Vissers JH; Harvey KF; Buchert M; Shi W; Ernst M; Chand AL
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 37957015
[TBL] [Abstract][Full Text] [Related]
18. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
19. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
20. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.
Kim M; Ly SH; Xie Y; Duronio GN; Ford-Roshon D; Hwang JH; Sulahian R; Rennhack JP; So J; Gjoerup O; Talamas JA; Grandclaudon M; Long HW; Doench JG; Sethi NS; Giannakis M; Hahn WC
Dev Cell; 2022 Jan; 57(2):212-227.e8. PubMed ID: 34990589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
